Abstract
Cleft lip ± cleft palate (CL/P) and cleft palate (CP) are the most common congenital craniofacial abnormalities with an estimated prevalence of 1:690 in the USA [1]. Both conditions can be divided into syndromic (associated with other abnormalities) and non-syndromic (isolated) with about 70 % of the cases with CL/P and 50 % of the cases with CP being non-syndromic [2]. In the USA, the prevalence of isolated cleft lip (CL) is 1:3226 live births, of isolated cleft lip and palate (CL + CP) 1:1786, and of isolated CP 1:1695 live births [1]. While the prevalence of CP is the same in different countries and ethnic backgrounds, the incidence of CL/P differs according to the race, ethnic background environmental exposures, socioeconomic status, and geographical origin. Thus, in the USA the prevalence of isolated CL/P is lowest among blacks and highest among American Indians. CL/P is also very high among the First Nations population in British Columbia, Canada [1/300] [3]. Furthermore, while CP is more common in females, CL/P is more common in males.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mai CT, Cassell CH, Meyer RE, Isenburg J, Canfield MA, Rickard R, Olney RS, Stallings EB, Beck M, Hashm SS, et al. Birth defects data from population‐based birth defects surveillance programs in the United States, 2007 to 2011: highlighting orofacial clefts. Birth Defects Res A Clin Mol Teratol. 2014;100:895–904.
Shi M, Wehby GL, Murray JC. Review on genetic variants and maternal smoking in the etiology of oral clefts and other birth defects. Birth Defects Res C Embryo Today Rev. 2008;84:16–29.
Lowry RB, Johnson CY, Gagnon F, Little J. Segregation analysis of cleft lip with or without cleft palate in the First Nations (Amerindian) people of British Columbia and review of isolated cleft palate etiologies. Birth Defects Res A Clin Mol Teratol. 2009;85:568–73.
Som PM, Naidich TP. Illustrated review of the embryology and development of the facial region, part 2: late development of the fetal face and changes in the face from the newborn to adulthood. AJNR Am J Neuroradiol. 2014;35:10–8.
Young DL, Schneider RA, Hu D, Helms JA. Genetic and teratogenic approaches to craniofacial development. Crit Rev Oral Biol Med. 2000;11:304–17.
Lu XC, Yu W, Tao Y, Zhao PL, Li K, Tang LJ, Zheng JY, Li L. Contribution of transforming growth factor α polymorphisms to nonsyndromic orofacial clefts: a HuGE review and meta-analysis. Am J Epidemiol. 2014;179:267–81.
Lidra AC, Romitti PA, Basart AM, Doetschman T, Leysens NJ, Daack-Hirsch S, Semina EV, Johnson LR, Machida J, Burds A, et al. Association of MSX1 and TGFB3 with nonsyndromic clefting in humans. Am J Hum Genet. 1998;63:557–68.
Blanton SH, Cortez A, Stal S, Mulliken JB, Finnell RH, Hecht JT. Variation in IRF6 contributes to nonsyndromic cleft lip and palate. Am J Med Genet A. 2005;37A:259–62.
van Rooij IALM, Swinkels DW, Blom HJ, Merkus HMWM, Steegers-Theunissen RPM. Vitamin and homocysteine status of mothers and infants and the risk of nonsyndromic orofacial clefts. Am J Obstet Gynecol. 2003;189:1155–60.
Hunt S, Russel A, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J, Craig J, et al. Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology. 2008;71:272–6.
Hyoun SC, Običan SG, Scialli AR. Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol. 2012;94:187–207.
Shaw GM, Wasserman CR, Lammer EJ, O’Malley CD, Murray JC, Basart AM, Tolarova MM. Orofacial clefts, parental cigarette smoking, and transforming growth factor-alpha gene variants. Am J Hum Genet. 1996;58:551–61.
Butali A, Little J, Chevrier C, Cordier S, Steegers-Theunissen R, Jugessur A, Oladugba B, Mossey PA. Folic acid supplementation use and the MTHFR C677T polymorphism in orofacial clefts etiology: an individual participant data pooled-analysis. Birth Defects Res A Clin Mol Teratol. 2013;97:509–14.
Fraser FC, Sajoo A. Teratogenic potential of corticosteroids in humans. Teratology. 1995;51:45–6.
Grosen D, Chevrier C, Skytthe A, Bille C, Mølsted K, Sivertsen A, Murray JC, Christensen K. A cohort study of recurrence patterns among more than 54,000 relatives of oral cleft cases in Denmark: support for the multifactorial threshold model of inheritance. J Med Genet. 2010;47:162–8.
Rasmussen SA, Wong LYC, Yang Q, May KM, Friedman JM. Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics. 2003;111:777–84.
Zollino M, Murdolo M, Marang G, Pecile V, Galasso C, Mazzanti L, Neri G. On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review. Am J Med Genet C Semin Med Genet. 2008;148C:257–69.
De Vries BB, Knight SJ, Homfray T, Smithson SF, Flint J, Winter RM. Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype? J Med Genet. 2001;38:175–8.
Digilio MC, Bernardini L, Mingarell R, Capolino R, Capalbo A, Giuffrida MG, Versacci P, Novelli A, Dallapiccola B. 3q29 Microdeletion: a mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter pairs. Am J Med Genet A. 2009;149A:1777–81.
Kondo S, Schutte BC, Richardson RJ, Bjork BC, Knight AS, Watanabe Y, Howard E, de Lima RLF, Daack-Hirsch S, Sander A, et al. Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes. Nat Genet. 2002;32:285–9.
Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJ, Stephens K, Robin NH, Moran RT, et al. Stickler syndrome. Seattle: University of Washington, Seattle; 1993.
Saka D, Trainor PA. Treacher Collins syndrome: unmasking the role of Tcof1/treacle. Int J Biochem Cell Biol. 2009;41:1229–32.
Cole P, Hatef DA, Kaufman Y, Magruder A, Bree A, Friedman E, Sindwani R, Hollier LH. Facial clefting and oroauditory pathway manifestations in ankyloblepharon-ectodermal defects-cleft lip/palate (AEC) syndrome. Am J Med Genet A. 2009;149A:1910–5.
Nowaczyk MJM, Irons MB. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet. 2012;160C:250–62.
Arora K, Thukral A, Das RR, Gupta N, Kabra M, Agarwal R. Fryns syndrome: a lethal birth defect with variable phenotypic expressions in siblings. Indian J Pediatr. 2014;81:614–6.
Hu CH, Liu YF, Yu JS, Ng YY, Chen SJ, Su PH, Chen JY. A MID1 gene mutation in a patient with Opitz G/BBB syndrome that altered the 3D structure of SPRY domain. Am J Med Genet A. 2012;158A:726–31.
Bisschoff IJ, Zeschnigk C, Horn D, Wellek B, Rieß A, Wessels M, Willems P, Jensen P, Busche A, Bekkebraten J, et al. Novel mutations including deletions of the entire OFD1 gene in 30 families with type 1 orofaciodigital syndrome: a study of the extensive clinical variability. Hum Mutat. 2013;34:237–47.
Tessier P. Anatomical classification facial, cranio-facial and latero-facial clefts. J Maxillofac Surg. 1976;4:69–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Koifman, A., Blaser, S., Chitayat, D. (2017). The Genetics of Facial Cleft. In: Tonni, G., Sepulveda, W., Wong, A. (eds) Prenatal Diagnosis of Orofacial Malformations. Springer, Cham. https://doi.org/10.1007/978-3-319-32516-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-32516-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32514-9
Online ISBN: 978-3-319-32516-3
eBook Packages: MedicineMedicine (R0)